• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

常见低密度脂蛋白受体变异体的功能特性与分类

Functional characterization and classification of frequent low-density lipoprotein receptor variants.

作者信息

Etxebarria Aitor, Benito-Vicente Asier, Palacios Lourdes, Stef Marianne, Cenarro Ana, Civeira Fernando, Ostolaza Helena, Martin Cesar

机构信息

Unidad de Biofísica (CSIC, UPV/EHU) and Departamento de Bioquímica, Universidad del País Vasco, Bilbao, 48080, Spain.

出版信息

Hum Mutat. 2015 Jan;36(1):129-41. doi: 10.1002/humu.22721. Epub 2014 Nov 27.

DOI:10.1002/humu.22721
PMID:25378237
Abstract

Familial hypercholesterolemia (FH) is an autosomal-dominant disorder mostly caused by mutations in the low-density lipoprotein receptor (LDLR) gene leading to increased risk for premature cardiovascular diseases. According to functional studies, LDLR mutations may be classified into five classes. The main objective of this study was to characterize seven LDLR variants previously detected in FH patients. Analysis by flow cytometry and confocal microscopy of LDLR activity demonstrate that all the studied variants are pathogenic. Among the mutations located in β-propeller, p.Trp577Gly and p.Ile624del were classified as class 2, whereas p.Arg416Trp and p.Thr454Asn as class 5. p.Phe800Glyfs*129 (located in the cytoplasmic domain), p.Cys155Tyr (located in the binding domain), and p.Asn825Lys (inside FxNPxY motif) were classified as class 2, 3, and 4, respectively. The results also show that LDLR activity of these class 4 and 5 variants is not completely abolished, showing a milder phenotype. We have also determined that statin response is more efficient lowering total cholesterol in heterozygous patients carrying p.Ile624del (class 2) compared with p.Arg416Trp and p.Thr454Asn (class 5) variants. In conclusion, these findings emphasize the importance of characterizing LDLR pathogenic variants to provide an indisputable FH diagnosis and to gain insight into the statin response depending on the LDLR class mutation.

摘要

家族性高胆固醇血症(FH)是一种常染色体显性疾病,主要由低密度脂蛋白受体(LDLR)基因突变引起,会增加早发性心血管疾病的风险。根据功能研究,LDLR突变可分为五类。本研究的主要目的是对先前在FH患者中检测到的7种LDLR变体进行特征描述。通过流式细胞术和共聚焦显微镜对LDLR活性进行分析表明,所有研究的变体均具有致病性。在位于β-螺旋桨的突变中,p.Trp577Gly和p.Ile624del被归类为2类,而p.Arg416Trp和p.Thr454Asn为5类。p.Phe800Glyfs*129(位于细胞质结构域)、p.Cys155Tyr(位于结合结构域)和p.Asn825Lys(在FxNPxY基序内)分别被归类为2类、3类和4类。结果还表明,这些4类和5类变体的LDLR活性并未完全丧失,表现出较轻的表型。我们还确定,与携带p.Arg416Trp和p.Thr454Asn(5类)变体的杂合患者相比,携带p.Ile624del(2类)的杂合患者使用他汀类药物降低总胆固醇的效果更显著。总之,这些发现强调了对LDLR致病变体进行特征描述的重要性,以便提供无可争议的FH诊断,并深入了解取决于LDLR类别突变的他汀类药物反应。

相似文献

1
Functional characterization and classification of frequent low-density lipoprotein receptor variants.常见低密度脂蛋白受体变异体的功能特性与分类
Hum Mutat. 2015 Jan;36(1):129-41. doi: 10.1002/humu.22721. Epub 2014 Nov 27.
2
Activity-associated effect of LDL receptor missense variants located in the cysteine-rich repeats.位于富含半胱氨酸重复序列中的低密度脂蛋白受体错义变体的活性相关效应。
Atherosclerosis. 2015 Feb;238(2):304-12. doi: 10.1016/j.atherosclerosis.2014.12.026. Epub 2014 Dec 20.
3
Presence and type of low density lipoprotein receptor (LDLR) mutation influences the lipid profile and response to lipid-lowering therapy in Brazilian patients with heterozygous familial hypercholesterolemia.巴西杂合子家族性高胆固醇血症患者的低密度脂蛋白受体(LDLR)突变的存在和类型会影响血脂谱和降脂治疗的反应。
Atherosclerosis. 2014 Mar;233(1):206-10. doi: 10.1016/j.atherosclerosis.2013.12.028. Epub 2014 Jan 4.
4
Pharmacogenetic aspects in familial hypercholesterolemia with the special focus on FHMarburg (FH p.W556R).家族性高胆固醇血症的药物遗传学方面,特别关注马尔堡型家族性高胆固醇血症(FH p.W556R)。
Clin Res Cardiol Suppl. 2012 Jun;7(Suppl 1):2-6. doi: 10.1007/s11789-012-0041-y.
5
Functional characterization of splicing and ligand-binding domain variants in the LDL receptor.LDL 受体剪接和配体结合域变异体的功能特征。
Hum Mutat. 2012 Jan;33(1):232-43. doi: 10.1002/humu.21630. Epub 2011 Nov 3.
6
Analysis of LDLR variants from homozygous FH patients carrying multiple mutations in the LDLR gene.分析 LDLR 基因中携带多个突变的纯合 FH 患者的 LDLR 变异体。
Atherosclerosis. 2017 Aug;263:163-170. doi: 10.1016/j.atherosclerosis.2017.06.014. Epub 2017 Jun 8.
7
Genetic and environmental factors affecting the response to statin therapy in patients with molecularly defined familial hypercholesterolaemia.影响分子明确的家族性高胆固醇血症患者他汀类药物治疗反应的遗传和环境因素。
Pharmacogenet Genomics. 2005 Apr;15(4):219-25. doi: 10.1097/01213011-200504000-00005.
8
Functional Analysis of LDLR (Low-Density Lipoprotein Receptor) Variants in Patient Lymphocytes to Assess the Effect of Evinacumab in Homozygous Familial Hypercholesterolemia Patients With a Spectrum of LDLR Activity.功能性分析 LDLR(低密度脂蛋白受体)变异在患者淋巴细胞中,以评估依维莫司在杂合子家族性高胆固醇血症患者中对 LDLR 活性谱的影响。
Arterioscler Thromb Vasc Biol. 2019 Nov;39(11):2248-2260. doi: 10.1161/ATVBAHA.119.313051. Epub 2019 Oct 3.
9
Functional analysis of new variants at the low-density lipoprotein receptor associated with familial hypercholesterolemia.与家族性高胆固醇血症相关的低密度脂蛋白受体新变体的功能分析。
Hum Mutat. 2019 Aug;40(8):1181-1190. doi: 10.1002/humu.23801. Epub 2019 Jun 18.
10
Genetic diagnosis of familial hypercholesterolemia in a South European outbreed population: influence of low-density lipoprotein (LDL) receptor gene mutations on treatment response to simvastatin in total, LDL, and high-density lipoprotein cholesterol.南欧远交人群家族性高胆固醇血症的基因诊断:低密度脂蛋白(LDL)受体基因突变对辛伐他汀治疗总胆固醇、低密度脂蛋白胆固醇和高密度脂蛋白胆固醇反应的影响
J Clin Endocrinol Metab. 2001 Oct;86(10):4926-32. doi: 10.1210/jcem.86.10.7899.

引用本文的文献

1
Pathways and Molecular Mechanisms Governing LDL Receptor Regulation.低密度脂蛋白受体调控的信号通路及分子机制
Circ Res. 2025 Apr 11;136(8):902-919. doi: 10.1161/CIRCRESAHA.124.323578. Epub 2025 Apr 10.
2
Pathogenicity of the LDLR c.97C>T (p.Gln33Ter) Mutation in Familial Hypercholesterolemia.家族性高胆固醇血症中低密度脂蛋白受体c.97C>T(p.Gln33Ter)突变的致病性
Mol Genet Genomic Med. 2024 Nov;12(11):e70030. doi: 10.1002/mgg3.70030.
3
Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis.
白细胞免疫球蛋白样受体 B1(LILRB1)通过维持胆固醇稳态来保护人多发性骨髓瘤细胞免受铁死亡。
Nat Commun. 2024 Jul 9;15(1):5767. doi: 10.1038/s41467-024-50073-x.
4
High-Throughput Microscopy Characterization of Rare Variants.罕见变异的高通量显微镜表征
JACC Basic Transl Sci. 2023 Jun 28;8(8):1010-1021. doi: 10.1016/j.jacbts.2023.03.013. eCollection 2023 Aug.
5
Novel Tools for Comprehensive Functional Analysis of LDLR (Low-Density Lipoprotein Receptor) Variants.用于全面功能分析 LDLR(低密度脂蛋白受体)变异体的新工具。
Int J Mol Sci. 2023 Jul 14;24(14):11435. doi: 10.3390/ijms241411435.
6
Calling and Phasing of Single-Nucleotide and Structural Variants of the Gene Using Oxford Nanopore MinION.使用 Oxford Nanopore MinION 对 基因的单核苷酸和结构变异进行调用和分相。
Int J Mol Sci. 2023 Feb 24;24(5):4471. doi: 10.3390/ijms24054471.
7
MLb-LDLr: A Machine Learning Model for Predicting the Pathogenicity of Missense Variants.MLb-LDLr:一种预测错义变异致病性的机器学习模型。
JACC Basic Transl Sci. 2021 Nov 22;6(11):815-827. doi: 10.1016/j.jacbts.2021.08.009. eCollection 2021 Nov.
8
Characterization of familial hypercholesterolemia in Taiwanese ischemic stroke patients.台湾缺血性中风患者家族性高胆固醇血症的特征。
Aging (Albany NY). 2021 Jul 27;13(15):19339-19351. doi: 10.18632/aging.203320.
9
Lipoprotein metabolism in familial hypercholesterolemia.家族性高胆固醇血症中的脂蛋白代谢。
J Lipid Res. 2021;62:100062. doi: 10.1016/j.jlr.2021.100062. Epub 2021 Mar 3.
10
Proteostasis Regulation in the Endoplasmic Reticulum: An Emerging Theme in the Molecular Pathology and Therapeutic Management of Familial Hypercholesterolemia.内质网中的蛋白质稳态调节:家族性高胆固醇血症分子病理学与治疗管理中的一个新兴主题
Front Genet. 2020 Sep 23;11:570355. doi: 10.3389/fgene.2020.570355. eCollection 2020.